Delivery Order SPE2DB22D3004-SPE2DB25FQL18
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,854.98 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets (500 count) on May 30, 2025, with completion scheduled for June 2, 2025. This is a firm fixed-price delivery order issued under a competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $1,789.72 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets (500 count) with an ultimate completion date of August 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order valued at $7,564.11 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets in quantities of 500 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, and was awarded on September 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,281.58 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets (500 count) with a firm fixed price contract type. This award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, carries no set-aside designation and was competitively awarded. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's...
- The Defense Logistics Agency has awarded a delivery order valued at $35,132.55 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets in quantities of 500 units. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 5, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,789.72 for 500 tablets of Topiramate 25 mg, with a completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,580.74 to AmerisourceBergen Drug Corp for the supply of Topiramate 50 mg tablets (1,000 count) under a firm fixed price contract. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets (500 count) under a firm fixed-price contract valued at $3,579.40. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order valued at $5,076.43 to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg, with an ultimate completion date of August 28, 2025. This competitive award, executed on August 27, 2025, utilizes firm fixed pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,005.03 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Topiramate 100 mg. This contract, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order operates under...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FQL18Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,034.90 to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg, with a completion date of April 28, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a routine pharmaceutical supply order to support federal medical procurement needs. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare systems and other federal agencies worldwide. AmerisourceBergen's substantial federal contract portfolio with DLA demonstrates its critical role as a major pharmaceutical distributor supporting Defense Health Agency requirements and other government healthcare systems through flexible, competitively awarded contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 4/25/25 |